• Research & Development

  New Implantable System for Remodulin for PAH Approved

  Posted by Pulmonary Hypertension News Moderator on August 3, 2018 at 7:44 am

  The U.S. Food and Drug Administration has approved Medtronic’s Implantable System for Remodulin, or ISR, to deliver Remodulin to patients with pulmonary arterial hypertension (PAH).

  Click here to read more. 

  What are your thoughts on this news?

  replied 7 years, 7 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply